Naturally occurring mixtures of Alternaria toxins: anti-estrogenic and genotoxic effects in vitro

Arch Toxicol. 2019 Oct;93(10):3021-3031. doi: 10.1007/s00204-019-02545-z. Epub 2019 Sep 26.

Abstract

Alternaria molds can produce a variety of different mycotoxins, often resulting in food contamination with chemical mixtures, posing a challenge for risk assessment. Some of these metabolites possess estrogenic properties, an effect whose toxicological relevance is questioned in the light of the strong genotoxic and cytotoxic properties of co-occurring toxins. Thus, we tested a complex extract from A. alternata for estrogenic properties in Ishikawa cells. By assessing alkaline phosphatase activity, we did not observe estrogen receptor (ER) activation at non-cytotoxic concentrations (≤ 10 µg/ml). Furthermore, an extract stripped of highly genotoxic perylene quinones also did not mediate estrogenic effects, despite diminished genotoxic properties in the comet assay (≥ 10 µg/ml). Interestingly, both extracts impaired the estrogenicity of 17β-estradiol (E2) at non-cytotoxic concentrations (5-10 µg/ml), indicating anti-estrogenic effects which could not be explained by the presence of known mycoestrogens. A mechanism for this unexpected result might be the activation of the aryl hydrocarbon receptor (AhR) by Alternaria metabolites, as indicated by the induction of CYP1A1 transcription. While a direct influence on the metabolism of E2 could not be confirmed by LC-MS/MS, literature describing a direct interplay of the AhR with estrogenic pathways points to a corresponding mode of action. Taken together, the present study indicates AhR-mediated anti-estrogenic effects as a novel mechanism of naturally co-occurring Alternaria toxin mixtures. Furthermore, our results confirm their genotoxic activity and raise questions about the contribution of still undiscovered metabolites to toxicological properties.

Keywords: DNA damage; Emerging mycotoxin; Endocrine disruption; Mixture; Xenoestrogens.

MeSH terms

  • Alternaria / metabolism*
  • Basic Helix-Loop-Helix Transcription Factors / metabolism
  • Cell Line, Tumor
  • Estradiol / metabolism
  • Estrogen Antagonists / administration & dosage
  • Estrogen Antagonists / isolation & purification
  • Estrogen Antagonists / toxicity*
  • Humans
  • Mutagens / administration & dosage
  • Mutagens / isolation & purification
  • Mutagens / toxicity
  • Mycotoxins / administration & dosage
  • Mycotoxins / isolation & purification
  • Mycotoxins / toxicity*
  • Receptors, Aryl Hydrocarbon / metabolism

Substances

  • AHR protein, human
  • Basic Helix-Loop-Helix Transcription Factors
  • Estrogen Antagonists
  • Mutagens
  • Mycotoxins
  • Receptors, Aryl Hydrocarbon
  • Estradiol